North China Pharmaceutical Subsidiary Passes GMP Compliance Inspection

MT NewswiresFeb 24 21:48 ET

North China Pharmaceutical (600812.SH) subsidiary passed the Pharmaceutical GMP compliance inspection.

North China Pharmaceutical (600812.SH) announced that its wholly-owned subsidiary, North China Pharmaceutical Group Shentai Pharmaceutical Co., Ltd...

Zhitong FinanceFeb 24 05:11 ET

Improved Revenues Required Before North China Pharmaceutical Company.Ltd (SHSE:600812) Stock's 28% Jump Looks Justified

Simply Wall StFeb 10 18:25 ET

North China Pharmaceutical Company.Ltd (SHSE:600812) Earnings and Shareholder Returns Have Been Trending Downwards for the Last Five Years, but the Stock Ascends 4.2% This Past Week

Simply Wall StFeb 8 21:09 ET

Private Companies Are North China Pharmaceutical Company.Ltd's (SHSE:600812) Biggest Owners and Were Rewarded After Market Cap Rose by CN¥583m Last Week

Simply Wall StJan 18 20:53 ET

Huabei Pharmaceutical: 2024 Annual Results Advance Announcement

SZSIJan 16 11:00 ET · Announcements